148 related articles for article (PubMed ID: 7478615)
1. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110.
Mazzarelli JM; Atkins GB; Geisberg JV; Ricciardi RP
Oncogene; 1995 Nov; 11(9):1859-64. PubMed ID: 7478615
[TBL] [Abstract][Full Text] [Related]
2. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
Hermonat PL; Santin AD; Zhan D
J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
[TBL] [Abstract][Full Text] [Related]
3. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
Massimi P; Pim D; Storey A; Banks L
Oncogene; 1996 Jun; 12(11):2325-30. PubMed ID: 8649772
[TBL] [Abstract][Full Text] [Related]
4. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
Brokaw JL; Yee CL; Münger K
Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAF(II)250 mutation.
Sekiguchi T; Nishimoto T; Hunter T
Oncogene; 1999 Mar; 18(10):1797-806. PubMed ID: 10086334
[TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.
Wong HK; Ziff EB
J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.
Maldonado E; Cabrejos ME; Banks L; Allende JE
J Cell Biochem; 2002; 85(4):663-9. PubMed ID: 11968006
[TBL] [Abstract][Full Text] [Related]
8. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
[TBL] [Abstract][Full Text] [Related]
9. Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex.
Dubrovskaya V; Lavigne AC; Davidson I; Acker J; Staub A; Tora L
EMBO J; 1996 Jul; 15(14):3702-12. PubMed ID: 8758937
[TBL] [Abstract][Full Text] [Related]
10. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300.
Avantaggiati ML; Carbone M; Graessmann A; Nakatani Y; Howard B; Levine AS
EMBO J; 1996 May; 15(9):2236-48. PubMed ID: 8641289
[TBL] [Abstract][Full Text] [Related]
11. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
[TBL] [Abstract][Full Text] [Related]
12. Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells.
Keaveney M; Berkenstam A; Feigenbutz M; Vriend G; Stunnenberg HG
Nature; 1993 Oct; 365(6446):562-6. PubMed ID: 8413615
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S
Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416
[TBL] [Abstract][Full Text] [Related]
14. p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding protein.
Martin DW; Subler MA; Muñoz RM; Brown DR; Deb SP; Deb S
Biochem Biophys Res Commun; 1993 Aug; 195(1):428-34. PubMed ID: 8395834
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation.
Boyd JM; Loewenstein PM; Tang Qq QQ; Yu L; Green M
J Virol; 2002 Feb; 76(3):1461-74. PubMed ID: 11773419
[TBL] [Abstract][Full Text] [Related]
16. Subregions of the adenovirus E1A transactivation domain target multiple components of the TFIID complex.
Geisberg JV; Chen JL; Ricciardi RP
Mol Cell Biol; 1995 Nov; 15(11):6283-90. PubMed ID: 7565781
[TBL] [Abstract][Full Text] [Related]
17. The transactivation domain of adenovirus E1A interacts with the C terminus of human TAF(II)135.
Mazzarelli JM; Mengus G; Davidson I; Ricciardi RP
J Virol; 1997 Oct; 71(10):7978-83. PubMed ID: 9311891
[TBL] [Abstract][Full Text] [Related]
18. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
Pearson A; Greenblatt J
Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
[TBL] [Abstract][Full Text] [Related]
19. The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD finger.
Gangloff YG; Pointud JC; Thuault S; Carré L; Romier C; Muratoglu S; Brand M; Tora L; Couderc JL; Davidson I
Mol Cell Biol; 2001 Aug; 21(15):5109-21. PubMed ID: 11438666
[TBL] [Abstract][Full Text] [Related]
20. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.
Dennig J; Beato M; Suske G
EMBO J; 1996 Oct; 15(20):5659-67. PubMed ID: 8896459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
